deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT02714543

Evaluation of Efficacy of Aloevera in the Treatment of Oral Submucous Fibrosis- A Clinical Study

Sponsor: The Oxford Dental College, Hospital and Research Center, Bangalore, India

Updated 5 times since 2017 Last updated: Mar 15, 2016 Started: Nov 30, 2013 Primary completion: Aug 31, 2015 Completion: Nov 30, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02714543, this PHASE3 trial focuses on Oral SubMucous Fibrosis and remains completed. Sponsored by The Oxford Dental College, Hospital and Research Center, Bangalore, India, it has been updated 5 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Nov 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • The Oxford Dental College, Hospital and Research Center, Bangalore, India
Data source: The Oxford Dental College, Hospital and Research Center, Bangalore, India

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.